Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07420400 · ClinicalTrials.gov registry record
Non-Invasive Detection of Right-to-Left Cardiac Shunts
A clinical trial of Patent Foramen Ovale (PFO), sponsored by Scripps Health.
- Recruiting
- Registry status
- 75
- Enrollment target
- 1
- Study location
NCT07420400: Recruiting study of Patent Foramen Ovale (PFO), sponsored by Scripps Health.
NCT07420400 is a study of Patent Foramen Ovale (PFO) that is actively recruiting participants, run by Scripps Health. The registered enrollment target is 75 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07420400, a study of Patent Foramen Ovale (PFO), is actively recruiting participants, sponsored by Scripps Health.
- RECRUITING
- Registry status
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will test the sensitivity of a novel, battery-powered, non-invasive ultrasound device to detect a right-to-left shunt
Primary Outcome
Sensitivity to detect right-to-left shunt compared with TEE as the gold standard
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Point-of-care ultrasound
Study Locations (1)
California
- Scripps Memorial Hospital La Jolla - La Jolla
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2026-01-07 |
| Est. Completion | 2027-03-01 |
What NCT07420400 shows while recruiting
NCT07420400 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 75 participants, a relatively small participant target.
The record links to 1 condition, with Patent Foramen Ovale (PFO) appearing as the primary indexed condition, and to 1 intervention - of which Point-of-care ultrasound is the first listed.
NCT07420400 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07420400 about?
NCT07420400 is a clinical study titled "Non-Invasive Detection of Right-to-Left Cardiac Shunts". This study will test the sensitivity of a novel, battery-powered, non-invasive ultrasound device to detect a right-to-left shunt
What is the current status of trial NCT07420400?
This trial is currently recruiting. The enrollment target is 75 participants. The study started on 2026-01-07. Estimated completion is 2027-03-01.
What conditions does trial NCT07420400 study?
This clinical trial studies the following conditions: Patent Foramen Ovale (PFO).
What interventions are being tested in trial NCT07420400?
The interventions under investigation include: Point-of-care ultrasound (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07420400?
This trial is sponsored by Scripps Health, which has 30 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07420400 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI